Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.
about
Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection.KSHV: pathways to tumorigenesis and persistent infectionUpregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stressRapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesisIntracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components.De novo infection with rhesus monkey rhadinovirus leads to the accumulation of multiple intranuclear capsid species during lytic replication but favors the release of genome-containing virions.Maturation and vesicle-mediated egress of primate gammaherpesvirus rhesus monkey rhadinovirus require inner tegument protein ORF52.Progressive accumulation of activated ERK2 within highly stable ORF45-containing nuclear complexes promotes lytic gammaherpesvirus infectionSusceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region.Pathology of rituximab-induced Kaposi sarcoma flareEndothelial cells support persistent gammaherpesvirus 68 infection.Regulation of CD1d expression and function by a herpesvirus infection.Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins.Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replicationHuman Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcomaNK cells and virus-related cancers.Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases.The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis.Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasionStructure and function of latency-associated nuclear antigen.Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acidKaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declinRole of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expressionKaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells.Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cellsSuppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200.KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes.ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.RNAs in the virion of Kaposi's sarcoma-associated herpesvirus.
P2860
Q24670607-3AE0C0BB-A4CB-4332-BAA4-F3B609169C7BQ27026000-8AFD25E8-7484-4813-AC38-B95F451E9584Q28472699-B11FFC79-B29E-4E2C-BC41-CDAD6B11B610Q28476740-D83EB628-2338-43CA-9512-E29640C361C5Q28536884-B9AD46CF-65AB-4A99-9E27-6C8AA9E03770Q28757509-F7F7BCEA-1751-474B-BB14-4B91759CDA69Q30311978-BE804334-4D8E-4C16-9573-8C1B69DDF9D9Q30408375-825D5B10-AFFD-47E9-A786-D6C602998AD9Q30413848-1AAE2A43-7060-4629-A1CF-1DC2F2E291FAQ30433906-E00A8B4F-CD46-4C3C-A109-E083C7C4E875Q30439948-71A2F93F-BA22-4E16-BED1-DBF256D9BCB4Q30440843-FE4D3DF9-F777-4931-BDC4-C29E546A97F5Q31156919-59F7B07A-3D3C-44FF-9BBD-89E347572873Q33227754-0D5EE6CC-2BC1-4152-B389-BFB6F672D811Q33354623-09121316-A8A9-414C-877D-DB83EA60D654Q33369078-5763BCA3-3237-40D5-9DDD-1D9E8132AE50Q33768331-15BA1451-C663-4D80-97E7-DF67865CEF84Q33882749-7A09F620-A499-4EF2-A36B-3EB673F66120Q34059252-2BF5D27B-0003-45F4-AAE1-9F2BEDE93E86Q34130226-C2C81BDD-F8E8-4B04-9D6E-EF2E31615C88Q34337237-D9123130-A073-4AC5-B5C0-296E4503870EQ34453408-A7E8FC7D-03C2-498F-875F-363282DDD9DEQ35066362-4A2640C2-66FF-4C32-92AB-6719229C56BCQ35077642-EE3E4D36-B736-45C5-993E-98ED2FDC9D38Q35124429-9DEC554A-8EA4-4BC0-8037-8E62451A6F85Q35128724-39687D53-9AF1-41A8-BE1D-DADC31433D6DQ35702343-457EC0BF-D19E-4E2E-872C-52EDC2B1E58DQ36155542-809B5DAA-DCEE-4C15-A324-6E4AD6911F72Q37010247-547A943D-1ABB-4A9C-8502-9A5F67DBB639Q38319392-92BA4B0C-D86C-4B1D-B41E-EFF46BB057CBQ40173444-12032BE3-356F-4BB0-A6A1-DC49D5D62B2DQ40267788-5081DF7D-7AA6-4F21-A41F-7916F7C957D3Q40384607-B8E93626-41B3-425C-A356-D6BA076E81AEQ41594489-31EE4464-C489-40B0-8674-B3E81779790EQ42196341-31B2BDC3-FF1D-48DC-ADED-C0B256EA95B2Q42562294-D9777B03-553B-4E8B-B335-D93C09A0F54BQ42931199-4F133FC8-E290-4928-801A-7D8CB3AE26F4Q42931216-9A8DA82D-BF4B-4320-B60E-EBA4F58A9251
P2860
Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@ast
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@en
type
label
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@ast
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@en
prefLabel
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@ast
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@en
P2093
P2860
P1433
P1476
Surface downregulation of majo ...... arcoma-associated herpesvirus.
@en
P2093
Costin Tomescu
Dean H Kedes
P2860
P304
P356
10.1128/JVI.77.17.9669-9684.2003
P577
2003-09-01T00:00:00Z